Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in ...
Morning Overview on MSN
Billionaires chase immortality as Harvard-backed startup wins FDA nod for 1st partial de-aging trial
The race to slow, halt, or even reverse aging has moved from science fiction into the regulatory record. A Harvard-linked startup, Life Biosciences, has secured clearance from the U.S. Food and Drug ...
In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers.
"Aging has a relatively simple explanation and is apparently reversible." The post Scientists Testing Controversial Human Rejuvenation Compound Called ER-100 appeared first on Futurism.
AUSTIN, Texas, March 07, 2025 (GLOBE NEWSWIRE) -- Renowned neuroscientist, psychiatrist, and author, Jeffrey A. Lieberman, M.D., and world-leading longevity scientist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results